Cellyan Biotechnology Co annual gross margin
2023
2024
2025
2026
Cellyan Biotechnology Co's gross margin was 10.32% for fiscal 2026.
View full Cellyan Biotechnology Co company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | 10.32% | −1.57 pp |
| 2025 | 2025-03-31 | 11.89% | −9.43 pp |
| 2024 | 2024-03-31 | 21.32% | −0.49 pp |
| 2023 | 2023-03-31 | 21.81% | — |
Between the periods ended 2023-03-31 and 2026-03-31, Cellyan Biotechnology Co's gross margin decreased from 21.81% to 10.32%, a change of −11.49 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cellyan Biotechnology Co source filings ↗